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1. Introduction  
Traditional microbiological methods, which involve the study of populations rather than 
individual cells, obscure heterogeneity of microorganisms. Now this phenomenon is widely 
reported and study of individual cells rather than populations seems to be highly 
reasonable. Differences between cells can be observed, especially in bacterial biofilm 
structure. In the case of wide variety of cells in the mixture, flow cytometry has proved to be 
a successful method in investigating varied populations of cells. This technique operates 
essentially by monitoring bacteria in suspension flowing, so that only one cell at a time 
passes by a sensor. The information acquired based on size and inner complexity of particles 
as well as fluorescence emission following previous staining can deliver great amount of 
information. This process also provides an immediate assessment of cells populations.  
Although more than three decades ago flow cytometry has been applied to measure bacteria 
(Paau et al. 1977, Bailey et al. 1977), its use in microbiology is still underestimated and far 
from fully utilized. One of the reasons for that is that bacteria in comparison to mammalian 
cells are so much more difficult to work with in terms of their size and cell structure. 
Nevertheless with increasingly sensitive equipment, flow cytometry is finding its utility in 
dealing with highly heterogeneous bacterial populations.  
The best known example of heterogeneity of bacteria is antibiotic resistance (Davey et al., 
2003; Falagas et al., 2008). It is defined as resistance to antibiotics expressed by a 
subpopulation of cells within strains susceptible to antibiotics according to traditional in-
vitro susceptibility testing. The heteroresistance has been observed in a range of microbes, 
including Staphylococcus aureus, coagulase-negative staphylococci, Acinetobacter 
baumannii , Mycobacterium tuberculosis, Streptococcus pneumoniae , Enterococcus faecium 
and Cryptococcus neoformans (Alvarez-Barrientos et al., 2000). Most observations on 
heteroresistance reported in the literature concern staphylococci resistant to methicillin, 
vancomycin, and/or inhibitors of teichoic acid synthesis (Finan at all., 2002). Recently, β-
lactams heteroresistance of S. pneumoniae and vancomycin heteroresistance of enterococci 
have been also reported (Hasman et al., 2006; Nottasorn et al., 2005). The mechanism of β-
lactams resistance is a change in the affinity of penicillin-binding proteins or overproduction 
of specific penicillin-binding proteins. Williamson et al. showed that at least five PBPs had 
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been found in E. faecalis. Vancomycin resistance is usually determined by one of the two 
related gene clusters, vanA and vanB, that encode a dehydrogenase (VanH or VanHB) and 
ligase (VanA or VanB). Expression of VanA- and VanB-type resistance is regulated by the 
VanRS and VanRBSB two-component regulatory systems, respectively (Arthur et al., 1992; 
Evers and Courvalin, 1996).  
As flow cytometry involves the study of single cells, it is an excellent method for studying 
heterogeneous populations. While analyzing many more cells than by conventional 
cytometry, rare cell types are more likely to be detected and the results are accessible to 
statistical analysis. The multiparametric nature of flow cytometric measurements is also an 
advantage. These include differences in cell size, DNA content or antigenic properties. 
Additionally, many supplementary modifications of flow cytometry are used. An example is 
the study of heterogenic vancomycin resistance with the use of reporter system for single-
cell analysis of van gene expression. In the study, plasmid containing gene coding a green 
fluorescent protein was constructed for fluorescence-activated cell sorter (FACS) analysis 
(Cormack et al., 1996).  
So far flow cytometry has been found useful in general microbiology with some clinical 
uses, as well as in its more specific branches such as environmental (Troussellier et al., 1999) 
or industrial microbiology (Gunasekera et al., 2000). First attempts to use flow cytometry for 
bacterial detection in body fluids are dated for the 80’s when a test was developed enabling 
E. coli detection in blood samples (Mansour et al., 1985). The approach using flow cytometry 
has been continued and was reported later to be successful in bile, pleural fluid, ascites and 
cerebrospinal fluid (Takashi et al., 2000). Lately new tools based on flow cytometry have 
been developed, providing detection of significant bacteriuria as well as enumeration of 
bacterial particles, appearing to be an effective screening method (Hiroshi et al., 2006). 
The emergence of multi-drug resistant microbial strains has emphasised the need for rapid 
detection method of antibiotic resistance and in this case as well flow cytometry appeared to 
be an extremely attractive tool.  
Population analysis, among others, is the golden standard for the identification of hetero 
resistant vancomycin intermediate Staphylococcus aureus (hVISA) due to the fact that a 
proportion of MRSA found to harbor hVISA can be up to 8.3%. Moreover, for as yet 
unknown reasons, virtually all clinical E. faecalis isolates are tolerant to β-lactams and 
glycopeptides. Minimal inhibitory concentrations (MICs) of antimicrobials remain the same 
but the minimal bactericidal concentrations (MBCs) increase in tolerance. 
Enterococcus faecalis usually plays a role in commensal flora in the human gastrointestinal 
tract. However, it can become a pathogen involved in various infections such as 
endocarditis, urinary tract infections, meningitis, sepsis and intraabdominal infections. It is 
also a leading cause of nosocomial infections, and the emergence of vancomycin- and 
multidrug-resistant E. faecalis in the clinical setting is of particular concern (Bizzini et al., 
2009). 
Here, the authors will present the analysis of heterogeneity of resistance studied by flow 
cytometry with use of fluorescent antibiotics binding bacterial cells and fluorescent probes 
targeting resistance genes. The proposal of vancomycin and methicilin heteroresistant strain 
model will be presented. With use of the model, results obtained for clinical E.faecalis and 
S.aureus strain are discussed.  
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2. Material and methods  
The study was performed on reference and clinical strains listed in Tab 1. Fourteen MRSA 
strains were isolated from patients of various wards of the University Clinical Centre in 
Gdańsk and 12 Enterococcus faecalis from patients of Kościerzyna Medical Centre. The 
staphylococcal strains were isolated in the hospital laboratory during the period March 2008 
to March 2009 and were sent to the Microbiology Department of the Medical University of 
Gdańsk for epidemiological typing. One isolate per patient was included in the study. 
Bacteria were cultured from swabs: wound (4 isolates), nose (2 isolates) and fluids: 
tracheostomy tube fluid (3 isolates), blood (1 isolate), abscess fluid (1 isolate), pus (1 isolate), 
bronchial fluid (1 isolate), urine (1 isolate). The data about clinical recognitions were not 
available. The isolates were cultured on sheep blood agar and were identified as S.aureus by 
colony morphology, a positive plasma coagulase reaction and by biochemical tests (API, 
bioMerieux, France). Resistance to methicillin was primary tested using disc diffusion 
method with cefoxitin disc (Clinical and Laboratory Standards Institute,2006) and then was 
confirmed by detection of mec A gene by the Polymerase Chain Reaction (PCR) as described 
previously (Barski et al., 1996). DNA of bacterial isolates was extracted according to the 
previous report (Barski et al., 1996). For further analyses, the isolates were subcultured on 
nutrient broth and stored with glycerol at - 70°C.  
Spa typing and BURP analyses. The polymorphic X region of the protein A gene (spa) was 
amplified from the isolates by PCR with primers and according to procedure described by 
Kobayashi (1999). Spa types were determined by using Ridom Staph Type software, 
according to Harmsen et al (2003). The spa types were clustered into spa–CCs (clonal 
complexes) using the algorithm BURP - based upon repeat pattern (Rupptisch et al., 2006). 
Phage typing was performed according to Blair and Williams (1961). Two sets of phages 
were used as follows: a basic set of 23 phages with additional phages 88,89,187 and an 
additional set of phages MR8, MR12, MR25, 30, 33, 38, M3, M5, 622, 56B supplied by the 
Central Public Health Laboratory in London for use on MRSA strains (Richardson et al., 
1999). The phages were used in concentrations at routine test dilution (RTD) and 100xRTD. 
Reactions for phages were noted as described by Blair and Williams (1961). The phage type 
was defined by all the phages with strong reaction.  
The susceptibility of the MRSA isolates to antimicrobial agents other than cefoxitin was 
determined by the disc diffusion method according to the guidelines (Clinical and Laboratory 
Standards Institute. 2006). The following drugs were used for test: erythromycin, clindamycin, 
ciprofloxacin, co–trimoxazole, tetracycline, gentamycin, vancomycin, teicoplanin, fusidic acid, 
rifampicin, linezolid, synercid, chloramphenicol. For isolates identified as resistant to 
erythromycin, but susceptible to clindamycin, D-test was performed to detect inducible 
clindamycin resistance. For vancomycin, additionally, the minimal inhibitory concentration 
(MIC) was determined by E-tests as described by the manufacturer (AB Biodisc, Sweden).  
Enterococci were identified by esculin hydrolysis on Coccosel agar (bioMerieux). Species-level 
identification was based on rapid Strep ID (bioMerieux). Susceptibility testing was performed 
by following the current guidelines of the National Committee for Clinical Laboratory 
Standards (2002). Isolates were additionally tested for resistance to nitrofurantoin, gentamycin, 
amikacin, tobramycin, kanamycin, streptomycin ,neomycin, penicilin, meropenem, ampicillin, 
piperacilin and differentiated by antibiotic resistance pattern.  
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No.  Clinical source Antibiotic resistance pattern Phage 
group 
Phage type  Spa 
type 
SA1 Urine Te C III 42E/53/75/83A 010 
SA1 Nose E Cc Cip III 54/75/83A 003 
SA3 Nose Sensitive I/V 55/94/96 018 
SA4 Tracheostomy 
tube fluid 
E Cc Cip III 47/54/75/83A 003 
SA5 Blood Cip Te C/ NT - 008 
SA6 Wound Cip Te C/ III 53/83A 2065 
SA7 Pus E Cc Cip Sxt Te Rf C/Ge  NT - 037 
SA8 Bronchial fluid E Cc Cip Te Ge NT - 008 
SA9 Tracheostomy 
tube fluid 
E Cc Cip Te Ge III 47/54/75/83A 008 
SA10 Tracheostomy 
tube fluid 
E Cc Cip C III 47/54/75/83A 151 
SA11 Wound E Cc Cip II 55/71 003 
SA1 Abscess E Cc Cip III 75/83A 003 
SA2 Wound E Cc Cip III 83A 003 
SA12 Wound E Cc Cip NT - 002 
SA ATCC 25923  - -  
SA ATCC 29213  - -  
E.F  wound Te,FM, Rf, E,CC,An,NN,K,S - -  
E.F  Bronchial fluid Te,Rf,E,CC,NN,K,N,Me,Am - -  
E.F  urine FM,C,E,CC,Ge,An,NN,K,S,N - -  
E.F  urine CC,An,NN,K,S,N, - -  
E.F  wound FM,Cip,Ra,C,CC,An,NN,K,S,N - -  
E.F  wound Te,FM,CC,Ge,NN,K,S,N - -  
E.F  faeces Te,FM,C,CC,An,NN,K,S - -  
E.F  wound Te,Rf,C,CC,An,NN,K,N,P, - -  
E.F  faeces Te,Cip,Ra,C,CC,NN,K, - -  
E.F  faeces Te,Ra,CC,NN, - -  
E.F  faeces Cip,Ra,C,CC,An,NN,K,S,N - -  
E.F  faeces FM,Cip,Rf,C,CC,An,NN,K,N,P,
Mem,Am,PIP 
- -  
E.F  ATTC 51299 Van-R - -  
E.F  ATTC 29212 Van-S - -  
S.A Staphylococcus aureus, E.F. Enterococcus faecalis, ICU- intensive care unit; DVA - dermatology, 
venerology, alergology department; E - erytromycin; Cc – clindamycin (/ -inducible resistance to 
macrolides); Cip -ciprofloxacin; Te - tetracycline; C - chloramphenicol; Rf – rifampicin; Sxt trimetoprim/ 
sulfamethoxazole; Ge – gentamicin NT - non- typable; ° - inhibition reaction with phages; Cc – clonal 
complex; MIC – minimal inhibitory concentration; Va –vancomycin; FM- Nitrofurantoin, , Ge-
gentamycin, AN- Amikacin, NN –Tobramycin, K- Kanamycin, S-streptomycin , N- Neomycin, P-
penicilin, MeM- Meropenem, AM- Ampicilin, PIP piperacilin  
Table 1. List of strains used in the study.  
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For flow cytometry analysis, the isolates were grown overnight on Tryptic Soy Broth (TSB) 
at 370C and standardized to OD 1 (600 nm). The cells were then centrifuged 5 min at 2500 
rpm, washed and suspended in 200 μl PBS buffer. The binding assay was carried out by 
adding solution of Bocillin @fl or vancomycin @fl respecitivelly to the cell suspension of 
each strain. The reaction mixtures were incubated for 30 min at 370C and centrifuged. The 
pellets were collected and washed three times in 1 ml of PBS. Fluorescence of particles was 
determined by a FACS Scan flow cytometer (Becton Dickinson, San Jose, CA, USA). 
2.1 Optymalisation of bocillin@fl and vancomycin@fl binding  
In the previous study the relation between fluorescence and amount of used bocillin@fl was 
described by equation below; 
 y = 4.469ln(x) + 3.427,  R² = 0.944 (1) 
Following these results (Jarzembowski et al., 2008) and similar results obtained during study 
of vancomycin @fl binding (Jarzembowski et al., 2009) we stained cells by addition of 
1μg/ml vancomycin@fl. Because of inductive mechanism of vancomycin resistance , before 
staining strain was cultured in presence of 2ug/ml vancomycin (Sigma). The reaction 
mixtures were incubated for 45 min at 370C and again centrifuged. The pellets were 
collected and washed three times in 1 ml of PBS. Fluorescence of particles was determined 
with the use of FACS Scan flow cytometer (Becton Dickinson, San Jose, CA, USA). Results of 
induction of reference resistant strain are shown on Fig 1.  
 
Fig. 1. Fluorescence (FL1) inducted (red) and uninducted (black) vancomycin resistant 
reference strain after staining with vancomycin@fl 
To ensure cell nature of analysed particles we have excluded from procedure particles sized 
below 1µm based on value for size standard (Polysciences. Inc) and particles with low PI 
(propidium iodide) binding (Fig2).  
2.2 Modeling of vancomycin heteroresistant strain  
Mixture of the reference strains in proportion staring from 1.25 up to 50 % of resistant cells 
were composed to create model of heteroresistant strain. Cells binding and not binding 
vancomycin @fl were differentiated by markers consisting of 99.69 % of susceptible (M1) 
and 94% of resistant (M2) cells (Fig 3) 
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Fig. 2. Green (x axis) vancomycin@fl fluorescence and red (y axis ) PI fluorescence reference 
susceptible strain. Only upper regions were included into further analysis.  
 
Fig. 3. Fluorescence (FL1) of mixed culture consisting of 25% resistant cells 
2.3 Design and testing of DNA probes  
Oligonucleotide probes were designed with the software package (Biosoft: Beacon Designer) 
and rRNA sequences were obtained from the Ribosomal Database Project (RDP) 
supplemented with newly deposited rRNA sequences from GenBank. As a positive control, 
Enfl84 probe (3′-ACGTGAGTTAACCTTTCTCC, Waar et al. 2005) targeting 16sRNA gene 
was used. Fluorescein-labelled oligonucleotides against selected specific target sequences 
(van genes) of E. faecalis were synthesized commercially (Metabion) and tested for specificity 
against the set of reference organisms. For hybridization, procedure described by Waar et al 
(2005) was adopted. Briefly, cell membrane was permeabilizated by incubation for 30 min at 
37 °C in permeabilization buffer consisting of 1 mg lysozyme ml−1 (DNA Gdańsk). The cells 
were then centrifuged 5 min at 2500 rpm, washed and suspended in 200μl PBS buffer. 
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Subsequently, 200μl hybridization buffer containing FITC- labelled probe (1ng ) was added. 
The probes were hybridizated at 500C for 45 min. 
3. Results and discussion  
Heteroresistance, defined as a presence of subpopulations of resistant cells within susceptible 
majority was observed against β-lactams and glycopeptides. However, mechanism of actions 
of these groups of antibiotics is different.  
The emergence of community acquired methicillin resistant Staphylococcus aureus (cMRSA) 
has renewed interest in the mechanisms of methicillin resistance (Okuma et al., 2002; Nunes 
et al., 2007). In contrast to vancomycin resistance, resistance to β-lactams (methicillin 
resistance) is constitutively mediated by a affinity change in penicillin-binding proteins 
(enzymes involved in cell wall synthesis). Because many genes are involved in cell wall 
biosynthesis, explanation of the nature of heterogeneous expression of methicillin resistance 
is very difficult (Markova et al., 2008). Since 2001, an increase in the number of MRSA 
strains with heteroresistance to oxacillin has been observed in the Netherlands. These strains 
can spread unnoticed, as their phenotypic heterogeneous resistance to beta-lactams affects 
the results of susceptibility testing (Wannet 2002). Coexistence of two subpopulations 
(susceptible and resistant) within a clinical isolate and expression of resistance only in a 
small number of cells leads to diagnostic problems in clinical laboratories (Markova et al., 
2008). In methicillin-resistant Staphylococcus strain degree of heterogeneity is quite low: 
only 1 CFU of 104–107 CFU are phenotypically resistant (De Lencastre et al., 1993).  
Invention of Bocillin@fl, commercially avaible fluorescent penicillin, significantly increased 
possibility of studying heteroresistance (Jarzembowski et al., 2010). Results of flow cytometry 
were found to be correlated with reference heteroresistant strain properties. Furthermore, use 
of fluorescent antibiotics in flow cytometry proved linear nature of heteroresistance (Fig.4.).  
 
Fig. 4. Variance of bocillin @fl binding by medical isolates of S.aureus in relation to reference 
value  
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However, even in susceptible cell culture we always detect at least 1.47% antibiotic unbinding 
particles so it seems that the number of resistant cells in this method is overestimated. 
Results of Markova et al study (2008) showed that also changes of cell structure can be 
involved in mechanism of heteroresistance. Both heteroresistant and methicillin susceptible 
strains (MSSA) may transform into cell wall-deficient form after exposure to sub tolerant 
conditions. The finding that methicillin sensitive strain and heteroresistant strain give rise to 
L-form colonial growth both on oxacillin-free and oxacillin-containing media appeared to be 
remarkable. It is known that the heterogeneous resistance phenotype of mecA-positive 
MRSA strains progresses to homogeneous resistance upon incubation with methicillin 
(Sakoulas et al., 2001). Study results of resistance demonstrate that differences reduction of 
antibiotic binding after preincubation can be proved with the use of flow cytometry (Fig.5). 
 
Fig. 5. Influence of incubation of heteroresistant strain with methicillin on Bocillin@fl binding  
In contrast to MSSA and heteroresistant strains, homogenic MRSA strains did not convert to 
the cell wall-deficient forms (Markova et al., 2008).  
Vancomycin resistance is an example of inductive reaction on presence of antibiotic. In 
presence of vancomycin high amount of cell wall precursor with low affinity to vancomycin 
(d-ala-d alla) is synthesized while native precursors are removed (Hasman et al., 2006). 
Because we aimed to detect resistant cells between susceptible majorities, the induction 
condition should be set to prevent inhibition of growth of susceptible strain. Thus, we set up 
inductive concentration below breakpoint value, at 0.016μg 0.8 μg, 2μg and 4μg/ml. The 
results showed optimal induction with final vancomycin concentration of 2μg/ml (data not 
shown). While there are no reference strains of different degree of vancomycin 
heteroresistance, model obtained by combination of resistant and susceptible strain was 
prepared. Vancomycin@fl binding by cells in this model is presented on fig 6. The high 
correlation between percentage of fluorescent particles and percentage of resistant cells can 
be seen. (Fig. 6) 
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Fig. 6. Correlation between fluorescence (empty circles ), FL1 positive particle (full circles) 
and percentage of resistant cells  
The obtained model of vancomycin heteroresistance was then used for analysis of clinical 
strains. The percentage of stained particles ranged from 6.07% in resistant up to 99.66% in 
susceptible reference strains. Percentage in resistant unindicted strains was similar to the 
susceptible one (94.62 %). Reference strains showed also differences in fluorescence but they 
were not so significant (Tab. 3.) Similar, constant divergence was observed in the study of 
methicillin heteroresistance (Jarzembowski et al., 2010). Despite satisfactory differentiation 
of heteroresistance, the results showed some limitations of the method. Even in resistant 
strains some particles bind vancomycin@fl according to the chosen criteria. Among clinical 
strains, the percentage of unstained particles varies from 46.32 to 98.53 while median 
fluorescence varied from 547 to 1980.96. (Tab 2.). Generally, fluorescence of staphylococci 
was higher than fluorescence of enterococci  
 
 
percentage of FL1
 positive particles 
Median 
fluorescence 
Mean fluorescence 
 per particle 
max in staphylococci 97.77 1980.96 37.01 
max in enterococci 98.53 1684.85 27.26 
Min in staphylococci 46.32 572.55 10.87 
Min in enterococci  90.47 547.37 9.01 
resistant reference strain 6.07 239.28 4.6 
Susceptible reference strain  99.69 10009.04 21.2 
Resistant uninducted strains 94.62 403.15 11.5 
Table 2. Comparison of estimator values in groups of strains 
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In contrast to results of MIC based screening of vancomycin resistance, the results obtained 
in flow cytometry suggest heteroresistance of some strains (Fig. 7). It is obvious if we 
consider that presence of heteroresistant strains in US and Europe is quite high. Nunes et al. 
(2007) found a prevalence of 8.5 % (9/106) of glycopeptides-heteroresistant staphylococci 
isolated from bacteremia while others 7.4% (Frebourg et al., 1998).  
None of the tested strains had a MIC value below 4μg/ml, so all of them should be 
considered as vancomycin susceptible. On the other hand, determination of MICs have 
shown good accuracy only to detect vancomycin intermediate Staphylococcus aureus 
(VISA) and fail in the detection of glycopeptides heteroresistant strains (Nunes et al., 2007). 
Heterogeneous phenotypes of clinical strains of S. aureus and CNS present MIC value below 
4μg/ml (Nunes et al., 2007). That is why heteroresistance of the strains could be missed out 
in routine diagnostic. 
The heteroresistance has been considered responsible for failure in the treatment. 
Unfortunately, there is no widely accepted method to detect heteroresistant strains. The lack 
of a standardized method makes it difficult to determine the clinical significance in the 
treatment of an infection with vancomycin. In the presence of vancomycin not only van 
genes change expression. There is some evidence that vancomycin influences biofilm 
formation, at least in S. epidermidis culture. Changes of cell surface structure and size seen 
in flow cytometry as SSC and FSC values were explained by the studied effect of the 
glycopeptide antibiotic on cell envelope properties and biofilm formation. SEM examination 
of cells grown in the presence of vancomycin revealed the presence of polymorphic form. 
Such changes in cell morphology could be the reason of extremely high fluorescence of some 
strains after staining with vancomycin@fl.  
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Fig. 7. Variance of vancomycin@fl binding by medical isolates of S.aureus and E. faecalis in 
relation to reference value  
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Both in study of vancomycin heteroresistance and study of methicillin resistance, median 
fluorescence per particle seems to be a very effective estimator (Fig. 1, 7). It is interesting to 
compare FCM results of “native ‘methicillin heteroresistance (Fig. 4) and “artificial’ model of 
vancomycin heteroresistance. Despite different resistance mechanism, changes of estimators 
are very similar. Both fluorescence and percentage of fluorescent particle decrease with 
amount of resistant cells (Fig. 7).  
Detailed information about mechanism of heteroresistance can be explained by the study of 
resistance gene expression. At the first stage of our ongoing study we adopt protocol 
described by Warr (2005) to detect 16sRNA gene. In fact, Fig. 8 demonstrates successful 
detection of E. faecalis cells in flow cytometry. Furthermore, the protocol used determines 
the amount of cells in mixed culture.  
 
Fig. 8. Correlation between percentages of detectable particles in FLOW-FISH and 
proportion of E. faecalis cells in mixed culture stained by fluorescent 16sRNA probe 
Detection of 16s RNA gene, which appeared to be successful in single cells, ranged between 
104 and 105 ribosomes and, consequently, as many copies of 5S and 16Sand 23S-like rRNAs 
(Amman et al., 1990) making it was quite easy to get satisfactory signal. Despite the proven 
usefulness, serious limitations of FLOW- FISH technique in its sensitivity and resolution 
constitute an obstacle. It is believed that probes containing nucleic acid analogs with higher 
affinity for DNA and RNA may have the potential to reduce these problems (Kelly et al., 
2009). An example of such probe is peptide nucleic acid (PNA), which binds to DNA and 
RNA with high affinity. 
For our study, we decided to use another class of nucleic acid analogs in which the ribose 
sugar is constrained by a methylene bridge between 20-oxygen and 40-carbon, resulting in 
an N-type (3-endo) conformation , so called locked nucleic acids (LNAs) (Kelly et al., 2009).  
LNA is able to hybridize with DNA and RNA according to Watson–Crick base-pairing rules 
and does so with unprecedented high affinity. As a result, LNAs have been shown to 
significantly improve the sensitivity and specificity.  
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This technique is expected to be particularly useful for the detection of lower mRNA 
transcript levels. In fact, preliminary results (Fig. 9) are promising. On the other hand, 
further studies are needed for validation of chosen approach.  
 
Fig. 9. Results of regulatory vancomycin gene detection with LNA probe (x axe- binding of 
probe, Y axe PI staining) 
3. Conclusion 
According to obtained results, fluorescent antibiotics are excellent tools both, for detection 
of resistance and studies of heteroresistance in flow cytometry. Model of vancomycin 
heteroresistance was successfully prepared and used in studies of clinical strains. Because it 
is believed that heteroresistance mechanism involves changes of cell structure, it is 
especially profitable in terms of antibiotic binding and changes in cell structure can be 
observed. However, overestimation of resistant cells in culture remain unsolved. 
Preliminary results of FLOW-FISH are also promising. It seems, that use of LNA probes 
allows to express detection in single cells in culture. On the other hand, it is obvious that 
further studies are needed to evaluate the specifity ad sensitivity of this approach.  
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